Barrow, Hanley, Mewhinney & Strauss’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-523,113
Closed -$41.9M 391
2025
Q4
$41.9M Sell
523,113
-36,859
-7% -$2.48M 0.14% 110
2025
Q3
$27.3M Buy
559,972
+79,138
+16% +$4.9M 0.09% 119
2025
Q2
$35.9M Buy
+480,834
New +$31.8M 0.12% 110
2018
Q4
Sell
-78,799
Closed -$9.03M 369
2018
Q3
$9.03M Sell
78,799
-24,195
-23% -$2.5M 0.01% 153
2018
Q2
$9.24M Sell
102,994
-19,357
-16% -$1.63M 0.01% 161
2018
Q1
$8.95M Sell
122,351
-14,492
-11% -$994K 0.01% 156
2017
Q4
$7.95M Buy
+136,843
New +$7.21M 0.01% 165
2016
Q1
Sell
-1,844,774
Closed -$59.5M 335
2015
Q4
$59.5M Sell
1,844,774
-395,067
-18% -$12.8M 0.09% 123
2015
Q3
$72.4M Sell
2,239,841
-96,222
-4% -$3.62M 0.11% 102
2015
Q2
$96.6M Sell
2,336,063
-9,908
-0.4% -$418K 0.13% 96
2015
Q1
$105M Sell
2,345,971
-2,900
-0.1% -$121K 0.14% 95
2014
Q4
$87.9M Sell
2,348,871
-493,243
-17% -$18.1M 0.12% 102
2014
Q3
$99.2M Sell
2,842,114
-84,410
-3% -$3.01M 0.14% 95
2014
Q2
$103M Sell
2,926,524
-116,145
-4% -$3.88M 0.14% 96
2014
Q1
$99.2M Buy
3,042,669
+2,084,460
+218% +$79.7M 0.14% 95
2013
Q4
$40.4M Buy
+958,209
New +$39.4M 0.06% 137

Other funds holding HAE

Barrow, Hanley, Mewhinney & Strauss's HAE Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 523,113 shares — an estimated $41.9M sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in HAE in Q4 2013 and held it in 16 quarters. The position peaked at $105M in Q1 2015. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 523,113 Haemonetics shares in Q1 2026, an estimated $41.9M.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Haemonetics in Q4 2013 and held it in 16 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Haemonetics position peaked at $105M in Q1 2015.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.